<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32743745</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0533</ISSN><JournalIssue CitedMedium="Internet"><Volume>142</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Acta neuropathologica</Title><ISOAbbreviation>Acta Neuropathol</ISOAbbreviation></Journal><ArticleTitle>The existence of A&#x3b2; strains and their potential for driving phenotypic heterogeneity in Alzheimer's disease.</ArticleTitle><Pagination><StartPage>17</StartPage><EndPage>39</EndPage><MedlinePgn>17-39</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00401-020-02201-2</ELocationID><Abstract><AbstractText>Reminiscent of the human prion diseases, there is considerable clinical and pathological variability in Alzheimer's disease, the most common human neurodegenerative condition. As in prion disorders, protein misfolding and aggregation is a hallmark feature of Alzheimer's disease, where the initiating event is thought to be the self-assembly of A&#x3b2; peptide into aggregates that deposit in the central nervous system. Emerging evidence suggests that A&#x3b2;, similar to the prion protein, can polymerize into a conformationally diverse spectrum of aggregate strains both in vitro and within the brain. Moreover, certain types of A&#x3b2; aggregates exhibit key hallmarks of prion strains including divergent biochemical attributes and the ability to induce distinct pathological phenotypes when intracerebrally injected into mouse models. In this review, we discuss the evidence demonstrating that A&#x3b2; can assemble into distinct strains of aggregates and how such strains may be primary drivers of the phenotypic heterogeneity in Alzheimer's disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lau</LastName><ForeName>Heather H C</ForeName><Initials>HHC</Initials><AffiliationInfo><Affiliation>Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Krembil Discovery Tower, Rm. 4KD481, 60 Leonard Ave., Toronto, ON, M5T 0S8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ingelsson</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Krembil Discovery Tower, Rm. 4KD481, 60 Leonard Ave., Toronto, ON, M5T 0S8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health and Caring Sciences/Geriatrics, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watts</LastName><ForeName>Joel C</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0002-2604-2925</Identifier><AffiliationInfo><Affiliation>Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Krembil Discovery Tower, Rm. 4KD481, 60 Leonard Ave., Toronto, ON, M5T 0S8, Canada. joel.watts@utoronto.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, University of Toronto, Toronto, Canada. joel.watts@utoronto.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MOP-136899</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Acta Neuropathol</MedlineTA><NlmUniqueID>0412041</NlmUniqueID><ISSNLinking>0001-6322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000072002">Prion Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017096" MajorTopicYN="N">Prion Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072002" MajorTopicYN="N">Prion Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32743745</ArticleId><ArticleId IdType="doi">10.1007/s00401-020-02201-2</ArticleId><ArticleId IdType="pii">10.1007/s00401-020-02201-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ahmed M, Davis J, Aucoin D, Sato T, Ahuja S, Aimoto S et al (2010) Structural conversion of neurotoxic amyloid-beta(1&#x2013;42) oligomers to fibrils. Nat Struct Mol Biol 17:561&#x2013;567. https://doi.org/10.1038/nsmb.1799</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.1799</ArticleId><ArticleId IdType="pubmed">20383142</ArticleId><ArticleId IdType="pmc">2922021</ArticleId></ArticleIdList></Reference><Reference><Citation>Aizenstein HJ, Nebes RD, Saxton JA, Price JC, Mathis CA, Tsopelas ND et al (2008) Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol 65:1509&#x2013;1517. https://doi.org/10.1001/archneur.65.11.1509</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.65.11.1509</ArticleId><ArticleId IdType="pubmed">19001171</ArticleId><ArticleId IdType="pmc">2636844</ArticleId></ArticleIdList></Reference><Reference><Citation>Aslund A, Sigurdson CJ, Klingstedt T, Grathwohl S, Bolmont T, Dickstein DL et al (2009) Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses. ACS Chem Biol 4:673&#x2013;684. https://doi.org/10.1021/cb900112v</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cb900112v</ArticleId><ArticleId IdType="pubmed">19624097</ArticleId><ArticleId IdType="pmc">2886514</ArticleId></ArticleIdList></Reference><Reference><Citation>Attems J, Jellinger KA, Lintner F (2005) Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathol 110:222&#x2013;231. https://doi.org/10.1007/s00401-005-1064-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-005-1064-y</ArticleId><ArticleId IdType="pubmed">16133541</ArticleId></ArticleIdList></Reference><Reference><Citation>Atwood CS, Scarpa RC, Huang X, Moir RD, Jones WD, Fairlie DP et al (2000) Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. J Neurochem 75:1219&#x2013;1233. https://doi.org/10.1046/j.1471-4159.2000.0751219.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2000.0751219.x</ArticleId><ArticleId IdType="pubmed">10936205</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachhuber T, Katzmarski N, McCarter JF, Loreth D, Tahirovic S, Kamp F et al (2015) Inhibition of amyloid-beta plaque formation by alpha-synuclein. Nat Med 21:802&#x2013;807. https://doi.org/10.1038/nm.3885</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3885</ArticleId><ArticleId IdType="pubmed">26099047</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee G, Adams ME, Jaunmuktane Z, Alistair Lammie G, Turner B, Wani M et al (2019) Early onset cerebral amyloid angiopathy following childhood exposure to cadaveric dura. Ann Neurol 85:284&#x2013;290. https://doi.org/10.1002/ana.25407</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25407</ArticleId><ArticleId IdType="pubmed">30597599</ArticleId><ArticleId IdType="pmc">6492172</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassil F, Brown HJ, Pattabhiraman S, Iwasyk JE, Maghames CM, Meymand ES et al (2020) Amyloid-beta (Abeta) plaques promote seeding and spreading of alpha-synuclein and tau in a mouse model of Lewy body disorders with Abeta pathology. Neuron 105(260&#x2013;275):e266. https://doi.org/10.1016/j.neuron.2019.10.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.10.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Benilova I, Karran E, De Strooper B (2012) The toxic Abeta oligomer and Alzheimer's disease: an emperor in need of clothes. Nat Neurosci 15:349&#x2013;357. https://doi.org/10.1038/nn.3028</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3028</ArticleId><ArticleId IdType="pubmed">22286176</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry DB, Lu D, Geva M, Watts JC, Bhardwaj S, Oehler A et al (2013) Drug resistance confounding prion therapeutics. Proc Natl Acad Sci USA 110:E4160&#x2013;4169. https://doi.org/10.1073/pnas.1317164110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1317164110</ArticleId><ArticleId IdType="pubmed">24128760</ArticleId><ArticleId IdType="pmc">3816483</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertini I, Gonnelli L, Luchinat C, Mao J, Nesi A (2011) A new structural model of Abeta40 fibrils. J Am Chem Soc 133:16013&#x2013;16022. https://doi.org/10.1021/ja2035859</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja2035859</ArticleId><ArticleId IdType="pubmed">21882806</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolmont T, Clavaguera F, Meyer-Luehmann M, Herzig MC, Radde R, Staufenbiel M et al (2007) Induction of tau pathology by intracerebral infusion of amyloid-beta-containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice. Am J Pathol 171:2012&#x2013;2020. https://doi.org/10.2353/ajpath.2007.070403</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2007.070403</ArticleId><ArticleId IdType="pubmed">18055549</ArticleId><ArticleId IdType="pmc">2111123</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389&#x2013;404. https://doi.org/10.1007/s00401-006-0127-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-006-0127-z</ArticleId><ArticleId IdType="pubmed">16906426</ArticleId><ArticleId IdType="pmc">3906709</ArticleId></ArticleIdList></Reference><Reference><Citation>Bugiani O, Giaccone G, Rossi G, Mangieri M, Capobianco R, Morbin M et al (2010) Hereditary cerebral hemorrhage with amyloidosis associated with the E693K mutation of APP. Arch Neurol 67:987&#x2013;995. https://doi.org/10.1001/archneurol.2010.178</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2010.178</ArticleId><ArticleId IdType="pubmed">20697050</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgold S, Bittner T, Dorostkar MM, Kieser D, Fuhrmann M, Mitteregger G et al (2011) In vivo multiphoton imaging reveals gradual growth of newborn amyloid plaques over weeks. Acta Neuropathol 121:327&#x2013;335. https://doi.org/10.1007/s00401-010-0787-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-010-0787-6</ArticleId><ArticleId IdType="pubmed">21136067</ArticleId></ArticleIdList></Reference><Reference><Citation>Cali I, Cohen ML, Hasmallyi US, Parchi P, Giaccone G, Collins SJ et al (2018) Iatrogenic Creutzfeldt-Jakob disease with Amyloid-beta pathology: an international study. Acta Neuropathol Commun 6:5. https://doi.org/10.1186/s40478-017-0503-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-017-0503-z</ArticleId><ArticleId IdType="pubmed">29310723</ArticleId><ArticleId IdType="pmc">5759292</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellano JM, Kim J, Stewart FR, Jiang H, DeMattos RB, Patterson BW et al (2011) Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci Transl Med 3:89ra57. https://doi.org/10.1126/scitranslmed.3002156</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3002156</ArticleId><ArticleId IdType="pubmed">21715678</ArticleId><ArticleId IdType="pmc">3192364</ArticleId></ArticleIdList></Reference><Reference><Citation>Cendrowska U, Silva PJ, Ait-Bouziad N, Muller M, Guven ZP, Vieweg S et al (2020) Unraveling the complexity of amyloid polymorphism using gold nanoparticles and cryo-EM. Proc Natl Acad Sci USA 117:6866&#x2013;6874. https://doi.org/10.1073/pnas.1916176117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1916176117</ArticleId><ArticleId IdType="pubmed">32161130</ArticleId><ArticleId IdType="pmc">7104366</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark CM, Pontecorvo MJ, Beach TG, Bedell BJ, Coleman RE, Doraiswamy PM et al (2012) Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-beta plaques: a prospective cohort study. Lancet Neurol 11:669&#x2013;678. https://doi.org/10.1016/S1474-4422(12)70142-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70142-4</ArticleId><ArticleId IdType="pubmed">22749065</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavaguera F, Akatsu H, Fraser G, Crowther RA, Frank S, Hench J et al (2013) Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc Natl Acad Sci USA 110:9535&#x2013;9540. https://doi.org/10.1073/pnas.1301175110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1301175110</ArticleId><ArticleId IdType="pubmed">23690619</ArticleId><ArticleId IdType="pmc">3677441</ArticleId></ArticleIdList></Reference><Reference><Citation>Cloe AL, Orgel JP, Sachleben JR, Tycko R, Meredith SC (2011) The Japanese mutant Abeta (DeltaE22-Abeta(1&#x2013;39)) forms fibrils instantaneously, with low-thioflavin T fluorescence: seeding of wild-type Abeta(1&#x2013;40) into atypical fibrils by DeltaE22-Abeta(1&#x2013;39). Biochemistry 50:2026&#x2013;2039. https://doi.org/10.1021/bi1016217</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi1016217</ArticleId><ArticleId IdType="pubmed">21291268</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen ML, Kim C, Haldiman T, ElHag M, Mehndiratta P, Pichet T et al (2015) Rapidly progressive Alzheimer's disease features distinct structures of amyloid-beta. Brain 138:1009&#x2013;1022. https://doi.org/10.1093/brain/awv006</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv006</ArticleId><ArticleId IdType="pubmed">25688081</ArticleId><ArticleId IdType="pmc">5014074</ArticleId></ArticleIdList></Reference><Reference><Citation>Colletier JP, Laganowsky A, Landau M, Zhao M, Soriaga AB, Goldschmidt L et al (2011) Molecular basis for amyloid-beta polymorphism. Proc Natl Acad Sci USA 108:16938&#x2013;16943. https://doi.org/10.1073/pnas.1112600108</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1112600108</ArticleId><ArticleId IdType="pubmed">21949245</ArticleId><ArticleId IdType="pmc">3193189</ArticleId></ArticleIdList></Reference><Reference><Citation>Collinge J, Clarke AR (2007) A general model of prion strains and their pathogenicity. Science 318:930&#x2013;936. https://doi.org/10.1126/science.1138718</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1138718</ArticleId><ArticleId IdType="pubmed">17991853</ArticleId></ArticleIdList></Reference><Reference><Citation>Colvin MT, Silvers R, Ni QZ, Can TV, Sergeyev I, Rosay M et al (2016) Atomic resolution structure of monomorphic Abeta42 amyloid fibrils. J Am Chem Soc 138:9663&#x2013;9674. https://doi.org/10.1021/jacs.6b05129</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.6b05129</ArticleId><ArticleId IdType="pubmed">27355699</ArticleId><ArticleId IdType="pmc">5389415</ArticleId></ArticleIdList></Reference><Reference><Citation>Condello C, Lemmin T, Stohr J, Nick M, Wu Y, Maxwell AM et al (2018) Structural heterogeneity and intersubject variability of Abeta in familial and sporadic Alzheimer's disease. Proc Natl Acad Sci USA 115:E782&#x2013;E791. https://doi.org/10.1073/pnas.1714966115</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1714966115</ArticleId><ArticleId IdType="pubmed">29311311</ArticleId><ArticleId IdType="pmc">5789926</ArticleId></ArticleIdList></Reference><Reference><Citation>Condello C, Schain A, Grutzendler J (2011) Multicolor time-stamp reveals the dynamics and toxicity of amyloid deposition. Sci Rep 1:19. https://doi.org/10.1038/srep00019</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep00019</ArticleId><ArticleId IdType="pubmed">22355538</ArticleId><ArticleId IdType="pmc">3216507</ArticleId></ArticleIdList></Reference><Reference><Citation>Condello C, Stoehr J (2018) Abeta propagation and strains: Implications for the phenotypic diversity in Alzheimer's disease. Neurobiol Dis 109:191&#x2013;200. https://doi.org/10.1016/j.nbd.2017.03.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2017.03.014</ArticleId><ArticleId IdType="pubmed">28359847</ArticleId></ArticleIdList></Reference><Reference><Citation>Cras P, van Harskamp F, Hendriks L, Ceuterick C, van Duijn CM, Stefanko SZ et al (1998) Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala&#x2013;&gt;Gly mutation. Acta Neuropathol 96:253&#x2013;260. https://doi.org/10.1007/s004010050892</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010050892</ArticleId><ArticleId IdType="pubmed">9754958</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook R, Verkkoniemi A, Perez-Tur J, Mehta N, Baker M, Houlden H et al (1998) A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat Med 4:452&#x2013;455. https://doi.org/10.1038/nm0498-452</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0498-452</ArticleId><ArticleId IdType="pubmed">9546792</ArticleId></ArticleIdList></Reference><Reference><Citation>Cukalevski R, Yang X, Meisl G, Weininger U, Bernfur K, Frohm B et al (2015) The Abeta40 and Abeta42 peptides self-assemble into separate homomolecular fibrils in binary mixtures but cross-react during primary nucleation. Chem Sci 6:4215&#x2013;4233. https://doi.org/10.1039/c4sc02517b</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c4sc02517b</ArticleId><ArticleId IdType="pubmed">29218188</ArticleId><ArticleId IdType="pmc">5707514</ArticleId></ArticleIdList></Reference><Reference><Citation>DaRocha-Souto B, Scotton TC, Coma M, Serrano-Pozo A, Hashimoto T, Sereno L et al (2011) Brain oligomeric beta-amyloid but not total amyloid plaque burden correlates with neuronal loss and astrocyte inflammatory response in amyloid precursor protein/tau transgenic mice. J Neuropathol Exp Neurol 70:360&#x2013;376. https://doi.org/10.1097/NEN.0b013e318217a118</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e318217a118</ArticleId><ArticleId IdType="pubmed">21487307</ArticleId></ArticleIdList></Reference><Reference><Citation>De Strooper B, Karran E (2016) The cellular phase of Alzheimer's disease. Cell 164:603&#x2013;615. https://doi.org/10.1016/j.cell.2015.12.056</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.12.056</ArticleId><ArticleId IdType="pubmed">26871627</ArticleId></ArticleIdList></Reference><Reference><Citation>Dean DN, Das PK, Rana P, Burg F, Levites Y, Morgan SE et al (2017) Strain-specific fibril propagation by an Abeta dodecamer. Sci Rep 7:40787. https://doi.org/10.1038/srep40787</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep40787</ArticleId><ArticleId IdType="pubmed">28098204</ArticleId><ArticleId IdType="pmc">5241678</ArticleId></ArticleIdList></Reference><Reference><Citation>Dear AJ, Michaels TCT, Meisl G, Klenerman D, Wu S, Perrett S et al (2020) Kinetic diversity of amyloid oligomers. Proc Natl Acad Sci USA. https://doi.org/10.1073/pnas.1922267117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1922267117</ArticleId><ArticleId IdType="pubmed">32414930</ArticleId><ArticleId IdType="pmc">7275774</ArticleId></ArticleIdList></Reference><Reference><Citation>Degerman Gunnarsson M, Ingelsson M, Blennow K, Basun H, Lannfelt L, Kilander L (2016) High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer's disease. Alzheimer's Res Ther 8:22. https://doi.org/10.1186/s13195-016-0191-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-016-0191-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Devanand DP, Michaels-Marston KS, Liu X, Pelton GH, Padilla M, Marder K et al (2000) Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry 157:1399&#x2013;1405. https://doi.org/10.1176/appi.ajp.157.9.1399</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.157.9.1399</ArticleId><ArticleId IdType="pubmed">10964854</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Fede G, Catania M, Maderna E, Ghidoni R, Benussi L, Tonoli E et al (2018) Molecular subtypes of Alzheimer's disease. Sci Rep 8:3269. https://doi.org/10.1038/s41598-018-21641-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-21641-1</ArticleId><ArticleId IdType="pubmed">29459625</ArticleId><ArticleId IdType="pmc">5818536</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K et al (2014) Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. Lancet Neurol 13:614&#x2013;629. https://doi.org/10.1016/S1474-4422(14)70090-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70090-0</ArticleId><ArticleId IdType="pubmed">24849862</ArticleId></ArticleIdList></Reference><Reference><Citation>Dujardin S, Commins C, Lathuiliere A, Beerepoot P, Fernandes AR, Kamath TV et al (2020) Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease. Nat Med. https://doi.org/10.1038/s41591-020-0938-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0938-9</ArticleId><ArticleId IdType="pubmed">32572268</ArticleId></ArticleIdList></Reference><Reference><Citation>Duyckaerts C, Delatour B, Potier MC (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118:5&#x2013;36. https://doi.org/10.1007/s00401-009-0532-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0532-1</ArticleId><ArticleId IdType="pubmed">19381658</ArticleId></ArticleIdList></Reference><Reference><Citation>Duyckaerts C, Sazdovitch V, Ando K, Seilhean D, Privat N, Yilmaz Z et al (2018) Neuropathology of iatrogenic Creutzfeldt-Jakob disease and immunoassay of French cadaver-sourced growth hormone batches suggest possible transmission of tauopathy and long incubation periods for the transmission of Abeta pathology. Acta Neuropathol 135:201&#x2013;212. https://doi.org/10.1007/s00401-017-1791-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1791-x</ArticleId><ArticleId IdType="pubmed">29209767</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisele YS, Bolmont T, Heikenwalder M, Langer F, Jacobson LH, Yan ZX et al (2009) Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation. Proc Natl Acad Sci USA 106:12926&#x2013;12931. https://doi.org/10.1073/pnas.0903200106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0903200106</ArticleId><ArticleId IdType="pubmed">19622727</ArticleId><ArticleId IdType="pmc">2722323</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisele YS, Obermuller U, Heilbronner G, Baumann F, Kaeser SA, Wolburg H et al (2010) Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science 330:980&#x2013;982. https://doi.org/10.1126/science.1194516</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1194516</ArticleId><ArticleId IdType="pubmed">20966215</ArticleId><ArticleId IdType="pmc">3233904</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkins MR, Wang T, Nick M, Jo H, Lemmin T, Prusiner SB et al (2016) Structural polymorphism of Alzheimer's beta-amyloid fibrils as controlled by an E22 Switch: a solid-state NMR study. J Am Chem Soc 138:9840&#x2013;9852. https://doi.org/10.1021/jacs.6b03715</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.6b03715</ArticleId><ArticleId IdType="pubmed">27414264</ArticleId><ArticleId IdType="pmc">5149419</ArticleId></ArticleIdList></Reference><Reference><Citation>Esparza TJ, Zhao H, Cirrito JR, Cairns NJ, Bateman RJ, Holtzman DM et al (2013) Amyloid-beta oligomerization in Alzheimer dementia versus high-pathology controls. Ann Neurol 73:104&#x2013;119. https://doi.org/10.1002/ana.23748</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23748</ArticleId><ArticleId IdType="pubmed">23225543</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcon B, Zhang W, Murzin AG, Murshudov G, Garringer HJ, Vidal R et al (2018) Structures of filaments from Pick's disease reveal a novel tau protein fold. Nature 561:137&#x2013;140. https://doi.org/10.1038/s41586-018-0454-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0454-y</ArticleId><ArticleId IdType="pubmed">30158706</ArticleId><ArticleId IdType="pmc">6204212</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcon B, Zhang W, Schweighauser M, Murzin AG, Vidal R, Garringer HJ et al (2018) Tau filaments from multiple cases of sporadic and inherited Alzheimer's disease adopt a common fold. Acta Neuropathol 136:699&#x2013;708. https://doi.org/10.1007/s00401-018-1914-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1914-z</ArticleId><ArticleId IdType="pubmed">30276465</ArticleId><ArticleId IdType="pmc">6208733</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcon B, Zivanov J, Zhang W, Murzin AG, Garringer HJ, Vidal R et al (2019) Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules. Nature 568:420&#x2013;423. https://doi.org/10.1038/s41586-019-1026-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1026-5</ArticleId><ArticleId IdType="pubmed">30894745</ArticleId><ArticleId IdType="pmc">6472968</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira D, Nordberg A, Westman E (2020) Biological subtypes of Alzheimer disease: a systematic review and meta-analysis. Neurology 94:436&#x2013;448. https://doi.org/10.1212/WNL.0000000000009058</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009058</ArticleId><ArticleId IdType="pubmed">32047067</ArticleId><ArticleId IdType="pmc">7238917</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzpatrick AWP, Falcon B, He S, Murzin AG, Murshudov G, Garringer HJ et al (2017) Cryo-EM structures of tau filaments from Alzheimer's disease. Nature 547:185&#x2013;190. https://doi.org/10.1038/nature23002</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature23002</ArticleId><ArticleId IdType="pubmed">28678775</ArticleId><ArticleId IdType="pmc">5552202</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontzek K, Lutz MI, Aguzzi A, Kovacs GG, Budka H (2016) Amyloid-beta pathology and cerebral amyloid angiopathy are frequent in iatrogenic Creutzfeldt-Jakob disease after dural grafting. Swiss Med Wkly 146:w14287. https://doi.org/10.4414/smw.2016.14287</Citation><ArticleIdList><ArticleId IdType="doi">10.4414/smw.2016.14287</ArticleId><ArticleId IdType="pubmed">26812492</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghaemmaghami S, Ahn M, Lessard P, Giles K, Legname G, DeArmond SJ et al (2009) Continuous quinacrine treatment results in the formation of drug-resistant prions. PLoS Pathog 5:e1000673</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000673</ArticleId></ArticleIdList></Reference><Reference><Citation>Giaccone G, Maderna E, Marucci G, Catania M, Erbetta A, Chiapparini L et al (2019) Iatrogenic early onset cerebral amyloid angiopathy 30 years after cerebral trauma with neurosurgery: vascular amyloid deposits are made up of both Abeta40 and Abeta42. Acta Neuropathol Commun 7:70. https://doi.org/10.1186/s40478-019-0719-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0719-1</ArticleId><ArticleId IdType="pubmed">31046829</ArticleId><ArticleId IdType="pmc">6498603</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbons GS, Lee VMY, Trojanowski JQ (2019) Mechanisms of cell-to-cell transmission of pathological tau: a review. JAMA Neurol 76:101&#x2013;108. https://doi.org/10.1001/jamaneurol.2018.2505</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2018.2505</ArticleId><ArticleId IdType="pubmed">30193298</ArticleId><ArticleId IdType="pmc">6382549</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldsbury C, Frey P, Olivieri V, Aebi U, Muller SA (2005) Multiple assembly pathways underlie amyloid-beta fibril polymorphisms. J Mol Biol 352:282&#x2013;298. https://doi.org/10.1016/j.jmb.2005.07.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2005.07.029</ArticleId><ArticleId IdType="pubmed">16095615</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomperts SN, Locascio JJ, Rentz D, Santarlasci A, Marquie M, Johnson KA et al (2013) Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia. Neurology 80:85&#x2013;91. https://doi.org/10.1212/WNL.0b013e31827b1a07</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31827b1a07</ArticleId><ArticleId IdType="pubmed">23243071</ArticleId><ArticleId IdType="pmc">3589197</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotz J, Chen F, van Dorpe J, Nitsch RM (2001) Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 293:1491&#x2013;1495. https://doi.org/10.1126/science.1062097</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1062097</ArticleId><ArticleId IdType="pubmed">11520988</ArticleId></ArticleIdList></Reference><Reference><Citation>Grabowski TJ, Cho HS, Vonsattel JP, Rebeck GW, Greenberg SM (2001) Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 49:697&#x2013;705. https://doi.org/10.1002/ana.1009</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.1009</ArticleId><ArticleId IdType="pubmed">11409420</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory GC, Halliday GM (2005) What is the dominant Abeta species in human brain tissue? A review. Neurotox Res 7:29&#x2013;41. https://doi.org/10.1007/BF03033774</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03033774</ArticleId><ArticleId IdType="pubmed">15639796</ArticleId></ArticleIdList></Reference><Reference><Citation>Gremer L, Scholzel D, Schenk C, Reinartz E, Labahn J, Ravelli RBG et al (2017) Fibril structure of amyloid-beta(1&#x2013;42) by cryo-electron microscopy. Science 358:116&#x2013;119. https://doi.org/10.1126/science.aao2825</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aao2825</ArticleId><ArticleId IdType="pubmed">28882996</ArticleId><ArticleId IdType="pmc">6080689</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu L, Guo Z (2013) Alzheimer's Abeta42 and Abeta40 peptides form interlaced amyloid fibrils. J Neurochem 126:305&#x2013;311. https://doi.org/10.1111/jnc.12202</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12202</ArticleId><ArticleId IdType="pubmed">23406382</ArticleId><ArticleId IdType="pmc">3716832</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo JL, Narasimhan S, Changolkar L, He Z, Stieber A, Zhang B et al (2016) Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice. J Exp Med 213:2635&#x2013;2654. https://doi.org/10.1084/jem.20160833</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20160833</ArticleId><ArticleId IdType="pubmed">27810929</ArticleId><ArticleId IdType="pmc">5110027</ArticleId></ArticleIdList></Reference><Reference><Citation>Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8:101&#x2013;112. https://doi.org/10.1038/nrm2101</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2101</ArticleId><ArticleId IdType="pubmed">17245412</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamaguchi T, Eisele YS, Varvel NH, Lamb BT, Walker LC, Jucker M (2012) The presence of A&#x3b2; seeds, and not age per se, is critical to the initiation of A&#x3b2; deposition in the brain. Acta Neuropathol 123:31&#x2013;37. https://doi.org/10.1007/s00401-011-0912-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0912-1</ArticleId><ArticleId IdType="pubmed">22101366</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamaguchi T, Taniguchi Y, Sakai K, Kitamoto T, Takao M, Murayama S et al (2016) Significant association of cadaveric dura mater grafting with subpial Abeta deposition and meningeal amyloid angiopathy. Acta Neuropathol 132:313&#x2013;315. https://doi.org/10.1007/s00401-016-1588-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1588-3</ArticleId><ArticleId IdType="pubmed">27314593</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao YN, Lu QX, Zhai YH, Wang HY, Wu MN, Hu MM et al (2018) Cerebral inoculation of human A53T alpha-synuclein reduces spatial memory decline and amyloid-beta aggregation in APP/PS1 transgenic mice of Alzheimer's disease. Brain Res Bull 143:116&#x2013;122. https://doi.org/10.1016/j.brainresbull.2018.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2018.10.003</ArticleId><ArticleId IdType="pubmed">30366065</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa K, Yamaguchi I, Omata S, Gejyo F, Naiki H (1999) Interaction between A beta(1&#x2013;42) and A beta(1&#x2013;40) in Alzheimer's beta-amyloid fibril formation in vitro. Biochemistry 38:15514&#x2013;15521. https://doi.org/10.1021/bi991161m</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi991161m</ArticleId><ArticleId IdType="pubmed">10569934</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatami A, Albay R 3rd, Monjazeb S, Milton S, Glabe C (2014) Monoclonal antibodies against Abeta42 fibrils distinguish multiple aggregation state polymorphisms in vitro and in Alzheimer disease brain. J Biol Chem 289:32131&#x2013;32143. https://doi.org/10.1074/jbc.M114.594846</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.594846</ArticleId><ArticleId IdType="pubmed">25281743</ArticleId><ArticleId IdType="pmc">4231689</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatami A, Monjazeb S, Milton S, Glabe CG (2017) Familial Alzheimer's disease mutations within the amyloid precursor protein alter the aggregation and conformation of the amyloid-beta peptide. J Biol Chem 292:3172&#x2013;3185. https://doi.org/10.1074/jbc.M116.755264</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.755264</ArticleId><ArticleId IdType="pubmed">28049728</ArticleId><ArticleId IdType="pmc">5336154</ArticleId></ArticleIdList></Reference><Reference><Citation>He Z, Guo JL, McBride JD, Narasimhan S, Kim H, Changolkar L et al (2018) Amyloid-beta plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat Med 24:29&#x2013;38. https://doi.org/10.1038/nm.4443</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4443</ArticleId><ArticleId IdType="pubmed">29200205</ArticleId></ArticleIdList></Reference><Reference><Citation>Heilbronner G, Eisele YS, Langer F, Kaeser SA, Novotny R, Nagarathinam A et al (2013) Seeded strain-like transmission of beta-amyloid morphotypes in APP transgenic mice. EMBO Rep 14:1017&#x2013;1022. https://doi.org/10.1038/embor.2013.137</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/embor.2013.137</ArticleId><ArticleId IdType="pubmed">23999102</ArticleId><ArticleId IdType="pmc">3818077</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendriks L, van Duijn CM, Cras P, Cruts M, Van Hul W, van Harskamp F et al (1992) Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet 1:218&#x2013;221. https://doi.org/10.1038/ng0692-218</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0692-218</ArticleId><ArticleId IdType="pubmed">1303239</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL et al (2015) Neuroinflammation in Alzheimer's disease. Lancet Neurol 14:388&#x2013;405. https://doi.org/10.1016/S1474-4422(15)70016-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(15)70016-5</ArticleId><ArticleId IdType="pubmed">25792098</ArticleId><ArticleId IdType="pmc">5909703</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrup K (2015) The case for rejecting the amyloid cascade hypothesis. Nat Neurosci 18:794&#x2013;799. https://doi.org/10.1038/nn.4017</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4017</ArticleId><ArticleId IdType="pubmed">26007212</ArticleId></ArticleIdList></Reference><Reference><Citation>Herve D, Porche M, Cabrejo L, Guidoux C, Tournier-Lasserve E, Nicolas G et al (2018) Fatal Abeta cerebral amyloid angiopathy 4 decades after a dural graft at the age of 2 years. Acta Neuropathol. https://doi.org/10.1007/s00401-018-1828-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1828-9</ArticleId><ArticleId IdType="pubmed">29508058</ArticleId></ArticleIdList></Reference><Reference><Citation>Holec SAM, Woerman AL (2020) Evidence of distinct alpha-synuclein strains underlying disease heterogeneity. Acta Neuropathol. https://doi.org/10.1007/s00401-020-02163-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02163-5</ArticleId><ArticleId IdType="pubmed">32440702</ArticleId></ArticleIdList></Reference><Reference><Citation>Houlden H, Baker M, McGowan E, Lewis P, Hutton M, Crook R et al (2000) Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations. Ann Neurol 48:806&#x2013;808</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1531-8249(200011)48:5&lt;806::AID-ANA18&gt;3.0.CO;2-F</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard R, Liu KY (2020) Questions EMERGE as Biogen claims aducanumab turnaround. Nat Rev Neurol 16:63&#x2013;64. https://doi.org/10.1038/s41582-019-0295-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0295-9</ArticleId><ArticleId IdType="pubmed">31784690</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingelsson M, Fukumoto H, Newell KL, Growdon JH, Hedley-Whyte ET, Frosch MP et al (2004) Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 62:925&#x2013;931. https://doi.org/10.1212/01.wnl.0000115115.98960.37</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000115115.98960.37</ArticleId><ArticleId IdType="pubmed">15037694</ArticleId></ArticleIdList></Reference><Reference><Citation>Ironside JW, Head MW (2004) Neuropathology and molecular biology of variant Creutzfeldt-Jakob disease. Curr Top Microbiol Immunol 284:133&#x2013;159. https://doi.org/10.1007/978-3-662-08441-0_6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-662-08441-0_6</ArticleId><ArticleId IdType="pubmed">15148991</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaunmuktane Z, Mead S, Ellis M, Wadsworth JD, Nicoll AJ, Kenny J et al (2015) Evidence for human transmission of amyloid-beta pathology and cerebral amyloid angiopathy. Nature 525:247&#x2013;250. https://doi.org/10.1038/nature15369</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature15369</ArticleId><ArticleId IdType="pubmed">26354483</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaunmuktane Z, Quaegebeur A, Taipa R, Viana-Baptista M, Barbosa R, Koriath C et al (2018) Evidence of amyloid-beta cerebral amyloid angiopathy transmission through neurosurgery. Acta Neuropathol. https://doi.org/10.1007/s00401-018-1822-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1822-2</ArticleId><ArticleId IdType="pubmed">29766299</ArticleId><ArticleId IdType="pmc">5904220</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeibouei S, Akbari ME, Kalbasi A, Aref AR, Ajoudanian M, Rezvani A et al (2019) Personalized medicine in breast cancer: pharmacogenomics approaches. Pharmgenomics Pers Med 12:59&#x2013;73. https://doi.org/10.2147/PGPM.S167886</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/PGPM.S167886</ArticleId><ArticleId IdType="pubmed">31213877</ArticleId><ArticleId IdType="pmc">6549747</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson AS, Berglind-Dehlin F, Karlsson G, Edwards K, Gellerfors P, Lannfelt L (2006) Physiochemical characterization of the Alzheimer's disease-related peptides A beta 1&#x2013;42Arctic and A beta 1&#x2013;42wt. FEBS J 273:2618&#x2013;2630. https://doi.org/10.1111/j.1742-4658.2006.05263.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2006.05263.x</ArticleId><ArticleId IdType="pubmed">16817891</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Murray ME, Whitwell JL, Parisi JE, Petrucelli L, Jack CR et al (2014) Staging TDP-43 pathology in Alzheimer's disease. Acta Neuropathol 127:441&#x2013;450. https://doi.org/10.1007/s00401-013-1211-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1211-9</ArticleId><ArticleId IdType="pubmed">24240737</ArticleId></ArticleIdList></Reference><Reference><Citation>Jucker M, Walker LC (2018) Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases. Nat Neurosci 21:1341&#x2013;1349. https://doi.org/10.1038/s41593-018-0238-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0238-6</ArticleId><ArticleId IdType="pubmed">30258241</ArticleId><ArticleId IdType="pmc">6375686</ArticleId></ArticleIdList></Reference><Reference><Citation>Jucker M, Walker LC (2013) Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501:45&#x2013;51. https://doi.org/10.1038/nature12481</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12481</ArticleId><ArticleId IdType="pubmed">24005412</ArticleId><ArticleId IdType="pmc">3963807</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalimo H, Lalowski M, Bogdanovic N, Philipson O, Bird TD, Nochlin D et al (2013) The Arctic AbetaPP mutation leads to Alzheimer's disease pathology with highly variable topographic deposition of differentially truncated Abeta. Acta Neuropathol Commun 1:60. https://doi.org/10.1186/2051-5960-1-60</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-1-60</ArticleId><ArticleId IdType="pubmed">24252272</ArticleId><ArticleId IdType="pmc">4226306</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallhoff V, Peethumnongsin E, Zheng H (2007) Lack of alpha-synuclein increases amyloid plaque accumulation in a transgenic mouse model of Alzheimer's disease. Mol Neurodegener 2:6. https://doi.org/10.1186/1750-1326-2-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-2-6</ArticleId><ArticleId IdType="pubmed">17367539</ArticleId><ArticleId IdType="pmc">1832188</ArticleId></ArticleIdList></Reference><Reference><Citation>Karran E, De Strooper B (2016) The amyloid cascade hypothesis: are we poised for success or failure? J Neurochem 139(Suppl 2):237&#x2013;252. https://doi.org/10.1111/jnc.13632</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13632</ArticleId><ArticleId IdType="pubmed">27255958</ArticleId></ArticleIdList></Reference><Reference><Citation>Katzmarski N, Ziegler-Waldkirch S, Scheffler N, Witt C, Abou-Ajram C, Nuscher B et al (2020) Abeta oligomers trigger and accelerate Abeta seeding. Brain Pathol 30:36&#x2013;45. https://doi.org/10.1111/bpa.12734</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12734</ArticleId><ArticleId IdType="pubmed">31099449</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman SK, Sanders DW, Thomas TL, Ruchinskas AJ, Vaquer-Alicea J, Sharma AM et al (2016) Tau prion strains dictate patterns of cell pathology, progression rate, and regional vulnerability in vivo. Neuron 92:796&#x2013;812. https://doi.org/10.1016/j.neuron.2016.09.055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.055</ArticleId><ArticleId IdType="pubmed">27974162</ArticleId><ArticleId IdType="pmc">5392364</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim T, Vidal GS, Djurisic M, William CM, Birnbaum ME, Garcia KC et al (2013) Human LilrB2 is a beta-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer's model. Science 341:1399&#x2013;1404. https://doi.org/10.1126/science.1242077</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1242077</ArticleId><ArticleId IdType="pubmed">24052308</ArticleId></ArticleIdList></Reference><Reference><Citation>Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP et al (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55:306&#x2013;319. https://doi.org/10.1002/ana.20009</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20009</ArticleId><ArticleId IdType="pubmed">14991808</ArticleId></ArticleIdList></Reference><Reference><Citation>Klunk WE, Lopresti BJ, Ikonomovic MD, Lefterov IM, Koldamova RP, Abrahamson EE et al (2005) Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain. J Neurosci 25:10598&#x2013;10606. https://doi.org/10.1523/JNEUROSCI.2990-05.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2990-05.2005</ArticleId><ArticleId IdType="pubmed">16291932</ArticleId><ArticleId IdType="pmc">6725842</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodali R, Williams AD, Chemuru S, Wetzel R (2010) Abeta(1&#x2013;40) forms five distinct amyloid structures whose beta-sheet contents and fibril stabilities are correlated. J Mol Biol 401:503&#x2013;517. https://doi.org/10.1016/j.jmb.2010.06.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2010.06.023</ArticleId><ArticleId IdType="pubmed">20600131</ArticleId><ArticleId IdType="pmc">2919579</ArticleId></ArticleIdList></Reference><Reference><Citation>Kollmer M, Close W, Funk L, Rasmussen J, Bsoul A, Schierhorn A et al (2019) Cryo-EM structure and polymorphism of Abeta amyloid fibrils purified from Alzheimer's brain tissue. Nat Commun 10:4760. https://doi.org/10.1038/s41467-019-12683-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12683-8</ArticleId><ArticleId IdType="pubmed">31664019</ArticleId><ArticleId IdType="pmc">6820800</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotzbauer PT, Trojanowsk JQ, Lee VM (2001) Lewy body pathology in Alzheimer's disease. J Mol Neurosci 17:225&#x2013;232. https://doi.org/10.1385/jmn:17:2:225</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/jmn:17:2:225</ArticleId><ArticleId IdType="pubmed">11816795</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Pate KM, Moss MA, Dean DN, Rangachari V (2014) Self-propagative replication of Abeta oligomers suggests potential transmissibility in Alzheimer disease. PLoS ONE 9:e111492. https://doi.org/10.1371/journal.pone.0111492</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0111492</ArticleId><ArticleId IdType="pubmed">25365422</ArticleId><ArticleId IdType="pmc">4218758</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar DK, Choi SH, Washicosky KJ, Eimer WA, Tucker S, Ghofrani J et al (2016) Amyloid-beta peptide protects against microbial infection in mouse and worm models of Alzheimer's disease. Sci Transl Med 8:340ra372. https://doi.org/10.1126/scitranslmed.aaf1059</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf1059</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar-Singh S, Cras P, Wang R, Kros JM, van Swieten J, Lubke U et al (2002) Dense-core senile plaques in the Flemish variant of Alzheimer's disease are vasocentric. Am J Pathol 161:507&#x2013;520. https://doi.org/10.1016/S0002-9440(10)64207-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)64207-1</ArticleId><ArticleId IdType="pubmed">12163376</ArticleId><ArticleId IdType="pmc">1850756</ArticleId></ArticleIdList></Reference><Reference><Citation>Kummer MP, Heneka MT (2014) Truncated and modified amyloid-beta species. Alzheimer's Res Ther 6:28. https://doi.org/10.1186/alzrt258</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/alzrt258</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam B, Masellis M, Freedman M, Stuss DT, Black SE (2013) Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome. Alzheimer's Res Ther 5:1. https://doi.org/10.1186/alzrt155</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/alzrt155</ArticleId></ArticleIdList></Reference><Reference><Citation>Landau SM, Horng A, Fero A, Jagust WJ, Alzheimer's Disease Neuroimaging I (2016) Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI. Neurology 86:1377&#x2013;1385. https://doi.org/10.1212/WNL.0000000000002576</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002576</ArticleId><ArticleId IdType="pubmed">26968515</ArticleId><ArticleId IdType="pmc">4831042</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau A, So RWL, Lau HHC, Sang JC, Ruiz-Riquelme A, Fleck SC et al (2020) Alpha-Synuclein strains target distinct brain regions and cell types. Nat Neurosci 23:21&#x2013;31. https://doi.org/10.1038/s41593-019-0541-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0541-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau HHC, Lau A, Watts JC (2018) Discriminating strains of self-propagating protein aggregates using a conformational stability assay. Methods Mol Biol 1777:339&#x2013;354. https://doi.org/10.1007/978-1-4939-7811-3_22</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-7811-3_22</ArticleId><ArticleId IdType="pubmed">29744847</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauren J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457:1128&#x2013;1132. https://doi.org/10.1038/nature07761</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07761</ArticleId><ArticleId IdType="pubmed">19242475</ArticleId><ArticleId IdType="pmc">2748841</ArticleId></ArticleIdList></Reference><Reference><Citation>Le TV, Crook R, Hardy J, Dickson DW (2001) Cotton wool plaques in non-familial late-onset Alzheimer disease. J Neuropathol Exp Neurol 60:1051&#x2013;1061. https://doi.org/10.1093/jnen/60.11.1051</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/60.11.1051</ArticleId><ArticleId IdType="pubmed">11706935</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SE, Rabinovici GD, Mayo MC, Wilson SM, Seeley WW, DeArmond SJ et al (2011) Clinicopathological correlations in corticobasal degeneration. Ann Neurol 70:327&#x2013;340. https://doi.org/10.1002/ana.22424</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22424</ArticleId><ArticleId IdType="pubmed">21823158</ArticleId><ArticleId IdType="pmc">3154081</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A et al (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440:352&#x2013;357. https://doi.org/10.1038/nature04533</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04533</ArticleId><ArticleId IdType="pubmed">16541076</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine H 3rd, Walker LC (2010) Molecular polymorphism of Abeta in Alzheimer's disease. Neurobiol Aging 31:542&#x2013;548. https://doi.org/10.1016/j.neurobiolaging.2008.05.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2008.05.026</ArticleId><ArticleId IdType="pubmed">18619711</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, van Duinen SG et al (1990) Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248:1124&#x2013;1126. https://doi.org/10.1126/science.2111584</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.2111584</ArticleId><ArticleId IdType="pubmed">2111584</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Browning S, Mahal SP, Oelschlegel AM, Weissmann C (2010) Darwinian evolution of prions in cell culture. Science 327:869&#x2013;872. https://doi.org/10.1126/science.1183218</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1183218</ArticleId><ArticleId IdType="pubmed">20044542</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Costantino I, Venugopalan N, Fischetti RF, Hyman BT, Frosch MP et al (2016) Amyloid structure exhibits polymorphism on multiple length scales in human brain tissue. Sci Rep 6:33079. https://doi.org/10.1038/srep33079</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep33079</ArticleId><ArticleId IdType="pubmed">27629394</ArticleId><ArticleId IdType="pmc">5024092</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenzo A, Yuan M, Zhang Z, Paganetti PA, Sturchler-Pierrat C, Staufenbiel M et al (2000) Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease. Nat Neurosci 3:460&#x2013;464. https://doi.org/10.1038/74833</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/74833</ArticleId><ArticleId IdType="pubmed">10769385</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu JX, Qiang W, Yau WM, Schwieters CD, Meredith SC, Tycko R (2013) Molecular structure of beta-amyloid fibrils in Alzheimer's disease brain tissue. Cell 154:1257&#x2013;1268. https://doi.org/10.1016/j.cell.2013.08.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.08.035</ArticleId><ArticleId IdType="pubmed">24034249</ArticleId></ArticleIdList></Reference><Reference><Citation>Luhrs T, Ritter C, Adrian M, Riek-Loher D, Bohrmann B, Dobeli H et al (2005) 3D structure of Alzheimer's amyloid-beta(1&#x2013;42) fibrils. Proc Natl Acad Sci USA 102:17342&#x2013;17347. https://doi.org/10.1073/pnas.0506723102</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0506723102</ArticleId><ArticleId IdType="pubmed">16293696</ArticleId><ArticleId IdType="pmc">1297669</ArticleId></ArticleIdList></Reference><Reference><Citation>Makowski L (2019) The structural basis of amyloid strains in Alzheimer&#x2019;s disease. ACS Biomater Sci Eng. https://doi.org/10.1021/acsbiomaterials.9b01302</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsbiomaterials.9b01302</ArticleId><ArticleId IdType="pubmed">33463291</ArticleId></ArticleIdList></Reference><Reference><Citation>Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M et al (2001) Beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc Natl Acad Sci USA 98:12245&#x2013;12250. https://doi.org/10.1073/pnas.211412398</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.211412398</ArticleId><ArticleId IdType="pubmed">11572944</ArticleId><ArticleId IdType="pmc">59799</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Sachse C, Hortschansky P, Grigorieff N, Fandrich M (2009) Abeta(1&#x2013;40) fibril polymorphism implies diverse interaction patterns in amyloid fibrils. J Mol Biol 386:869&#x2013;877. https://doi.org/10.1016/j.jmb.2008.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2008.11.005</ArticleId><ArticleId IdType="pubmed">19038266</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E et al (2006) Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313:1781&#x2013;1784. https://doi.org/10.1126/science.1131864</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1131864</ArticleId><ArticleId IdType="pubmed">16990547</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer-Luehmann M, Spires-Jones TL, Prada C, Garcia-Alloza M, de Calignon A, Rozkalne A et al (2008) Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature 451:720&#x2013;724. https://doi.org/10.1038/nature06616</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06616</ArticleId><ArticleId IdType="pubmed">18256671</ArticleId><ArticleId IdType="pmc">3264491</ArticleId></ArticleIdList></Reference><Reference><Citation>Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW et al (2012) National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol 123:1&#x2013;11. https://doi.org/10.1007/s00401-011-0910-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0910-3</ArticleId><ArticleId IdType="pubmed">22101365</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales R, Duran-Aniotz C, Castilla J, Estrada LD, Soto C (2012) De novo induction of amyloid-&#x3b2; deposition in vivo. Mol Psychiatry. https://doi.org/10.1038/mp.2011.120</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2011.120</ArticleId><ArticleId IdType="pubmed">21968933</ArticleId></ArticleIdList></Reference><Reference><Citation>Moro ML, Giaccone G, Lombardi R, Indaco A, Uggetti A, Morbin M et al (2012) APP mutations in the Abeta coding region are associated with abundant cerebral deposition of Abeta38. Acta Neuropathol 124:809&#x2013;821. https://doi.org/10.1007/s00401-012-1061-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1061-x</ArticleId><ArticleId IdType="pubmed">23143229</ArticleId></ArticleIdList></Reference><Reference><Citation>Narasimhan S, Guo JL, Changolkar L, Stieber A, McBride JD, Silva LV et al (2017) Pathological tau strains from human brains recapitulate the diversity of tauopathies in nontransgenic mouse brain. J Neurosci 37:11406&#x2013;11423. https://doi.org/10.1523/JNEUROSCI.1230-17.2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1230-17.2017</ArticleId><ArticleId IdType="pubmed">29054878</ArticleId><ArticleId IdType="pmc">5700423</ArticleId></ArticleIdList></Reference><Reference><Citation>Naslund J, Haroutunian V, Mohs R, Davis KL, Davies P, Greengard P et al (2000) Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 283:1571&#x2013;1577. https://doi.org/10.1001/jama.283.12.1571</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.12.1571</ArticleId><ArticleId IdType="pubmed">10735393</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C et al (2001) The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nat Neurosci 4:887&#x2013;893. https://doi.org/10.1038/nn0901-887</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn0901-887</ArticleId><ArticleId IdType="pubmed">11528419</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsson KP, Aslund A, Berg I, Nystrom S, Konradsson P, Herland A, Inganas O et al (2007) Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer's disease using novel luminescent probes. ACS Chem Biol 2:553&#x2013;560. https://doi.org/10.1021/cb700116u</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cb700116u</ArticleId><ArticleId IdType="pubmed">17672509</ArticleId></ArticleIdList></Reference><Reference><Citation>Noble GP, Wang DW, Walsh DJ, Barone JR, Miller MB, Nishina KA et al (2015) A Structural and functional comparison between infectious and non-infectious autocatalytic recombinant PrP conformers. PLoS Pathog 11:e1005017. https://doi.org/10.1371/journal.ppat.1005017</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005017</ArticleId><ArticleId IdType="pubmed">26125623</ArticleId><ArticleId IdType="pmc">4488359</ArticleId></ArticleIdList></Reference><Reference><Citation>Nystrom S, Psonka-Antonczyk KM, Ellingsen PG, Johansson LB, Reitan N, Handrick S et al (2013) Evidence for age-dependent in vivo conformational rearrangement within Abeta amyloid deposits. ACS Chem Biol 8:1128&#x2013;1133. https://doi.org/10.1021/cb4000376</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cb4000376</ArticleId><ArticleId IdType="pubmed">23521783</ArticleId></ArticleIdList></Reference><Reference><Citation>Obici L, Demarchi A, de Rosa G, Bellotti V, Marciano S, Donadei S et al (2005) A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy. Ann Neurol 58:639&#x2013;644. https://doi.org/10.1002/ana.20571</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20571</ArticleId><ArticleId IdType="pubmed">16178030</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono K, Takahashi R, Ikeda T, Yamada M (2012) Cross-seeding effects of amyloid beta-protein and alpha-synuclein. J Neurochem 122:883&#x2013;890. https://doi.org/10.1111/j.1471-4159.2012.07847.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2012.07847.x</ArticleId><ArticleId IdType="pubmed">22734715</ArticleId></ArticleIdList></Reference><Reference><Citation>Ossenkoppele R, Schonhaut DR, Scholl M, Lockhart SN, Ayakta N, Baker SL et al (2016) Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Brain 139:1551&#x2013;1567. https://doi.org/10.1093/brain/aww027</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww027</ArticleId><ArticleId IdType="pubmed">26962052</ArticleId><ArticleId IdType="pmc">5006248</ArticleId></ArticleIdList></Reference><Reference><Citation>Paravastu AK, Leapman RD, Yau WM, Tycko R (2008) Molecular structural basis for polymorphism in Alzheimer's beta-amyloid fibrils. Proc Natl Acad Sci USA 105:18349&#x2013;18354. https://doi.org/10.1073/pnas.0806270105</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0806270105</ArticleId><ArticleId IdType="pubmed">19015532</ArticleId><ArticleId IdType="pmc">2587602</ArticleId></ArticleIdList></Reference><Reference><Citation>Paravastu AK, Qahwash I, Leapman RD, Meredith SC, Tycko R (2009) Seeded growth of beta-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure. Proc Natl Acad Sci USA 106:7443&#x2013;7448. https://doi.org/10.1073/pnas.0812033106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0812033106</ArticleId><ArticleId IdType="pubmed">19376973</ArticleId><ArticleId IdType="pmc">2678625</ArticleId></ArticleIdList></Reference><Reference><Citation>Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O et al (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224&#x2013;233</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1531-8249(199908)46:2&lt;224::AID-ANA12&gt;3.0.CO;2-W</ArticleId></ArticleIdList></Reference><Reference><Citation>Parchi P, Strammiello R, Notari S, Giese A, Langeveld JP, Ladogana A et al (2009) Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrP<sup>Sc</sup> types: an updated classification. Acta Neuropathol 118:659&#x2013;671. https://doi.org/10.1007/s00401-009-0585-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0585-1</ArticleId><ArticleId IdType="pubmed">19718500</ArticleId><ArticleId IdType="pmc">2773124</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauwels K, Williams TL, Morris KL, Jonckheere W, Vandersteen A, Kelly G et al (2012) Structural basis for increased toxicity of pathological abeta42:abeta40 ratios in Alzheimer disease. J Biol Chem 287:5650&#x2013;5660. https://doi.org/10.1074/jbc.M111.264473</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.264473</ArticleId><ArticleId IdType="pubmed">22157754</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Nievas BG, Stein TD, Tai HC, Dols-Icardo O, Scotton TC, Barroeta-Espar I et al (2013) Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology. Brain 136:2510&#x2013;2526. https://doi.org/10.1093/brain/awt171</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt171</ArticleId><ArticleId IdType="pubmed">23824488</ArticleId><ArticleId IdType="pmc">3722351</ArticleId></ArticleIdList></Reference><Reference><Citation>Petkova AT, Leapman RD, Guo Z, Yau WM, Mattson MP, Tycko R (2005) Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science 307:262&#x2013;265. https://doi.org/10.1126/science.1105850</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1105850</ArticleId><ArticleId IdType="pubmed">15653506</ArticleId></ArticleIdList></Reference><Reference><Citation>Petkova AT, Yau WM, Tycko R (2006) Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. Biochemistry 45:498&#x2013;512. https://doi.org/10.1021/bi051952q</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi051952q</ArticleId><ArticleId IdType="pubmed">16401079</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccini A, Russo C, Gliozzi A, Relini A, Vitali A, Borghi R et al (2005) beta-amyloid is different in normal aging and in Alzheimer disease. J Biol Chem 280:34186&#x2013;34192. https://doi.org/10.1074/jbc.M501694200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M501694200</ArticleId><ArticleId IdType="pubmed">16103127</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirisinu L, Di Bari MA, D'Agostino C, Marcon S, Riccardi G, Poleggi A et al (2016) Gerstmann-Straussler-Scheinker disease subtypes efficiently transmit in bank voles as genuine prion diseases. Sci Rep 6:20443. https://doi.org/10.1038/srep20443</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep20443</ArticleId><ArticleId IdType="pubmed">26841849</ArticleId><ArticleId IdType="pmc">4740801</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M, Stoeck K, Glatzel M, Vey M, Bellon A, Aguzzi A (2005) Coexistence of multiple PrP<sup>Sc</sup> types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol 4:805&#x2013;814. https://doi.org/10.1016/S1474-4422(05)70225-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(05)70225-8</ArticleId><ArticleId IdType="pubmed">16297838</ArticleId></ArticleIdList></Reference><Reference><Citation>Prusiner SB (2012) Cell biology. A unifying role for prions in neurodegenerative diseases. Science 336:1511&#x2013;1513. https://doi.org/10.1126/science.1222951</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1222951</ArticleId><ArticleId IdType="pubmed">22723400</ArticleId><ArticleId IdType="pmc">3942086</ArticleId></ArticleIdList></Reference><Reference><Citation>Purro SA, Farrow MA, Linehan J, Nazari T, Thomas DX, Chen Z et al (2018) Transmission of amyloid-beta protein pathology from cadaveric pituitary growth hormone. Nature 564:415&#x2013;419. https://doi.org/10.1038/s41586-018-0790-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0790-y</ArticleId><ArticleId IdType="pubmed">30546139</ArticleId><ArticleId IdType="pmc">6708408</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiang W, Kelley K, Tycko R (2013) Polymorph-specific kinetics and thermodynamics of beta-amyloid fibril growth. J Am Chem Soc 135:6860&#x2013;6871. https://doi.org/10.1021/ja311963f</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja311963f</ArticleId><ArticleId IdType="pubmed">23627695</ArticleId><ArticleId IdType="pmc">3686096</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiang W, Yau WM, Lu JX, Collinge J, Tycko R (2017) Structural variation in amyloid-beta fibrils from Alzheimer's disease clinical subtypes. Nature 541:217&#x2013;221. https://doi.org/10.1038/nature20814</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20814</ArticleId><ArticleId IdType="pubmed">28052060</ArticleId><ArticleId IdType="pmc">5233555</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen J, Mahler J, Beschorner N, Kaeser SA, Hasler LM, Baumann F et al (2017) Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer's disease. Proc Natl Acad Sci USA 114:13018&#x2013;13023. https://doi.org/10.1073/pnas.1713215114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1713215114</ArticleId><ArticleId IdType="pubmed">29158413</ArticleId><ArticleId IdType="pmc">5724274</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinke AA, Gestwicki JE (2011) Insight into amyloid structure using chemical probes. Chem Biol Drug Des 77:399&#x2013;411. https://doi.org/10.1111/j.1747-0285.2011.01110.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1747-0285.2011.01110.x</ArticleId><ArticleId IdType="pubmed">21457473</ArticleId><ArticleId IdType="pmc">3097318</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie DL, Adlard P, Peden AH, Lowrie S, Le Grice M, Burns K et al (2017) Amyloid-beta accumulation in the CNS in human growth hormone recipients in the UK. Acta Neuropathol 134:221&#x2013;240. https://doi.org/10.1007/s00401-017-1703-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1703-0</ArticleId><ArticleId IdType="pubmed">28349199</ArticleId><ArticleId IdType="pmc">5508038</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson JL, Lee EB, Xie SX, Rennert L, Suh E, Bredenberg C et al (2018) Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain 141:2181&#x2013;2193. https://doi.org/10.1093/brain/awy146</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy146</ArticleId><ArticleId IdType="pubmed">29878075</ArticleId><ArticleId IdType="pmc">6022546</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen RF, Ciliax BJ, Wingo TS, Gearing M, Dooyema J, Lah JJ et al (2010) Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer's disease. Acta Neuropathol 119:221&#x2013;233. https://doi.org/10.1007/s00401-009-0583-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0583-3</ArticleId><ArticleId IdType="pubmed">19690877</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen RF, Tomidokoro Y, Farberg AS, Dooyema J, Ciliax B, Preuss TM et al (2016) Comparative pathobiology of beta-amyloid and the unique susceptibility of humans to Alzheimer's disease. Neurobiol Aging 44:185&#x2013;196. https://doi.org/10.1016/j.neurobiolaging.2016.04.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.04.019</ArticleId><ArticleId IdType="pubmed">27318146</ArticleId><ArticleId IdType="pmc">4913040</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen RF, Walker LC, Levine H 3rd (2011) PIB binding in aged primate brain: enrichment of high-affinity sites in humans with Alzheimer's disease. Neurobiol Aging 32:223&#x2013;234. https://doi.org/10.1016/j.neurobiolaging.2009.02.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2009.02.011</ArticleId><ArticleId IdType="pubmed">19329226</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Riquelme A, Lau HHC, Stuart E, Goczi AN, Wang Z, Schmitt-Ulms G et al (2018) Prion-like propagation of beta-amyloid aggregates in the absence of APP overexpression. Acta Neuropathol Commun 6:26. https://doi.org/10.1186/s40478-018-0529-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0529-x</ArticleId><ArticleId IdType="pubmed">29615128</ArticleId><ArticleId IdType="pmc">5883524</ArticleId></ArticleIdList></Reference><Reference><Citation>Saborio GP, Permanne B, Soto C (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411:810&#x2013;813. https://doi.org/10.1038/35081095</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35081095</ArticleId><ArticleId IdType="pubmed">11459061</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachse C, Fandrich M, Grigorieff N (2008) Paired beta-sheet structure of an Abeta(1&#x2013;40) amyloid fibril revealed by electron microscopy. Proc Natl Acad Sci USA 105:7462&#x2013;7466. https://doi.org/10.1073/pnas.0712290105</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0712290105</ArticleId><ArticleId IdType="pubmed">18483195</ArticleId><ArticleId IdType="pmc">2396686</ArticleId></ArticleIdList></Reference><Reference><Citation>Safar JG, Xiao X, Kabir ME, Chen S, Kim C, Haldiman T et al (2015) Structural determinants of phenotypic diversity and replication rate of human prions. PLoS Pathog 11:e1004832. https://doi.org/10.1371/journal.ppat.1004832</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004832</ArticleId><ArticleId IdType="pubmed">25875953</ArticleId><ArticleId IdType="pmc">4397081</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito T, Suemoto T, Brouwers N, Sleegers K, Funamoto S, Mihira N et al (2011) Potent amyloidogenicity and pathogenicity of Abeta43. Nat Neurosci 14:1023&#x2013;1032. https://doi.org/10.1038/nn.2858</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2858</ArticleId><ArticleId IdType="pubmed">21725313</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvadores N, Shahnawaz M, Scarpini E, Tagliavini F, Soto C (2014) Detection of misfolded Abeta oligomers for sensitive biochemical diagnosis of Alzheimer's disease. Cell Rep 7:261&#x2013;268. https://doi.org/10.1016/j.celrep.2014.02.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.02.031</ArticleId><ArticleId IdType="pubmed">24656814</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders DW, Kaufman SK, DeVos SL, Sharma AM, Mirbaha H, Li A et al (2014) Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 82:1271&#x2013;1288. https://doi.org/10.1016/j.neuron.2014.04.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.04.047</ArticleId><ArticleId IdType="pubmed">24857020</ArticleId><ArticleId IdType="pmc">4171396</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, Apostol MI et al (2007) Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 447:453&#x2013;457. https://doi.org/10.1038/nature05695</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05695</ArticleId><ArticleId IdType="pubmed">17468747</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt C, Wolff M, Weitz M, Bartlau T, Korth C, Zerr I (2011) Rapidly progressive Alzheimer disease. Arch Neurol 68:1124&#x2013;1130. https://doi.org/10.1001/archneurol.2011.189</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.189</ArticleId><ArticleId IdType="pubmed">21911694</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt M, Rohou A, Lasker K, Yadav JK, Schiene-Fischer C, Fandrich M et al (2015) Peptide dimer structure in an Abeta(1&#x2013;42) fibril visualized with cryo-EM. Proc Natl Acad Sci USA 112:11858&#x2013;11863. https://doi.org/10.1073/pnas.1503455112</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1503455112</ArticleId><ArticleId IdType="pubmed">26351699</ArticleId><ArticleId IdType="pmc">4586870</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt M, Sachse C, Richter W, Xu C, Fandrich M, Grigorieff N (2009) Comparison of Alzheimer Abeta(1&#x2013;40) and Abeta(1&#x2013;42) amyloid fibrils reveals similar protofilament structures. Proc Natl Acad Sci USA 106:19813&#x2013;19818. https://doi.org/10.1073/pnas.0905007106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0905007106</ArticleId><ArticleId IdType="pubmed">19843697</ArticleId><ArticleId IdType="pmc">2764733</ArticleId></ArticleIdList></Reference><Reference><Citation>Sehlin D, Fang XT, Cato L, Antoni G, Lannfelt L, Syvanen S (2016) Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's disease. Nat Commun 7:10759. https://doi.org/10.1038/ncomms10759</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms10759</ArticleId><ArticleId IdType="pubmed">26892305</ArticleId><ArticleId IdType="pmc">4762893</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med 8:595&#x2013;608. https://doi.org/10.15252/emmm.201606210</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201606210</ArticleId><ArticleId IdType="pubmed">27025652</ArticleId><ArticleId IdType="pmc">4888851</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahnawaz M, Mukherjee A, Pritzkow S, Mendez N, Rabadia P, Liu X et al (2020) Discriminating alpha-synuclein strains in Parkinson's disease and multiple system atrophy. Nature 578:273&#x2013;277. https://doi.org/10.1038/s41586-020-1984-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-1984-7</ArticleId><ArticleId IdType="pubmed">32025029</ArticleId><ArticleId IdType="pmc">7066875</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I et al (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14:837&#x2013;842. https://doi.org/10.1038/nm1782</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1782</ArticleId><ArticleId IdType="pubmed">18568035</ArticleId><ArticleId IdType="pmc">2772133</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepherd C, McCann H, Halliday GM (2009) Variations in the neuropathology of familial Alzheimer's disease. Acta Neuropathol 118:37&#x2013;52. https://doi.org/10.1007/s00401-009-0521-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0521-4</ArticleId><ArticleId IdType="pubmed">19306098</ArticleId></ArticleIdList></Reference><Reference><Citation>Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B et al (2010) The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS ONE 5:e9505. https://doi.org/10.1371/journal.pone.0009505</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009505</ArticleId><ArticleId IdType="pubmed">20209079</ArticleId><ArticleId IdType="pmc">2831066</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto C, Pritzkow S (2018) Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat Neurosci 21:1332&#x2013;1340. https://doi.org/10.1038/s41593-018-0235-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0235-9</ArticleId><ArticleId IdType="pubmed">30250260</ArticleId><ArticleId IdType="pmc">6432913</ArticleId></ArticleIdList></Reference><Reference><Citation>Stohr J, Condello C, Watts JC, Bloch L, Oehler A, Nick M et al (2014) Distinct synthetic Abeta prion strains producing different amyloid deposits in bigenic mice. Proc Natl Acad Sci USA 111:10329&#x2013;10334. https://doi.org/10.1073/pnas.1408968111</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1408968111</ArticleId><ArticleId IdType="pubmed">24982137</ArticleId><ArticleId IdType="pmc">4104853</ArticleId></ArticleIdList></Reference><Reference><Citation>Stohr J, Watts JC, Mensinger ZL, Oehler A, Grillo SK, DeArmond SJ et al (2012) Purified and synthetic Alzheimer's amyloid beta (Abeta) prions. Proc Natl Acad Sci USA 109:11025&#x2013;11030. https://doi.org/10.1073/pnas.1206555109</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1206555109</ArticleId><ArticleId IdType="pubmed">22711819</ArticleId><ArticleId IdType="pmc">3390876</ArticleId></ArticleIdList></Reference><Reference><Citation>Tellechea P, Pujol N, Esteve-Belloch P, Echeveste B, Garcia-Eulate MR, Arbizu J et al (2018) Early- and late-onset Alzheimer disease: Are they the same entity? Neurologia 33:244&#x2013;253. https://doi.org/10.1016/j.nrl.2015.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2015.08.002</ArticleId><ArticleId IdType="pubmed">26546285</ArticleId></ArticleIdList></Reference><Reference><Citation>Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, Gabizon R et al (1996) Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274:2079&#x2013;2082. https://doi.org/10.1126/science.274.5295.2079</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.274.5295.2079</ArticleId><ArticleId IdType="pubmed">8953038</ArticleId></ArticleIdList></Reference><Reference><Citation>Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791&#x2013;1800. https://doi.org/10.1212/wnl.58.12.1791</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.58.12.1791</ArticleId><ArticleId IdType="pubmed">12084879</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran J, Chang D, Hsu F, Wang H, Guo Z (2017) Cross-seeding between Abeta40 and Abeta42 in Alzheimer's disease. FEBS Lett 591:177&#x2013;185. https://doi.org/10.1002/1873-3468.12526</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.12526</ArticleId><ArticleId IdType="pubmed">27981583</ArticleId></ArticleIdList></Reference><Reference><Citation>Tycko R (2015) Amyloid polymorphism: structural basis and neurobiological relevance. Neuron 86:632&#x2013;645. https://doi.org/10.1016/j.neuron.2015.03.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.03.017</ArticleId><ArticleId IdType="pubmed">25950632</ArticleId><ArticleId IdType="pmc">4425266</ArticleId></ArticleIdList></Reference><Reference><Citation>Vergara C, Houben S, Suain V, Yilmaz Z, De Decker R, Vanden Dries V et al (2019) Amyloid-beta pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo. Acta Neuropathol 137:397&#x2013;412. https://doi.org/10.1007/s00401-018-1953-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1953-5</ArticleId><ArticleId IdType="pubmed">30599077</ArticleId></ArticleIdList></Reference><Reference><Citation>Villain N, Dubois B (2019) Alzheimer's Disease Including Focal Presentations. Semin Neurol 39:213&#x2013;226. https://doi.org/10.1055/s-0039-1681041</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0039-1681041</ArticleId><ArticleId IdType="pubmed">30925614</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker L, McAleese KE, Thomas AJ, Johnson M, Martin-Ruiz C, Parker C et al (2015) Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. Acta Neuropathol 129:729&#x2013;748. https://doi.org/10.1007/s00401-015-1406-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1406-3</ArticleId><ArticleId IdType="pubmed">25758940</ArticleId></ArticleIdList></Reference><Reference><Citation>Walti MA, Ravotti F, Arai H, Glabe CG, Wall JS, Bockmann A et al (2016) Atomic-resolution structure of a disease-relevant Abeta(1&#x2013;42) amyloid fibril. Proc Natl Acad Sci USA 113:E4976&#x2013;4984. https://doi.org/10.1073/pnas.1600749113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1600749113</ArticleId><ArticleId IdType="pubmed">27469165</ArticleId><ArticleId IdType="pmc">5003276</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Duo L, Hsu F, Xue C, Lee YK, Guo Z (2020) Polymorphic Abeta42 fibrils adopt similar secondary structure but differ in cross-strand side chain stacking interactions within the same beta-sheet. Sci Rep 10:5720. https://doi.org/10.1038/s41598-020-62181-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-62181-x</ArticleId><ArticleId IdType="pubmed">32235842</ArticleId><ArticleId IdType="pmc">7109039</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Muiznieks LD, Ghosh P, Williams D, Solarski M, Fang A et al (2017) Somatostatin binds to the human amyloid beta peptide and favors the formation of distinct oligomers. eLife. https://doi.org/10.7554/eLife.28401</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.28401</ArticleId><ArticleId IdType="pubmed">29284554</ArticleId><ArticleId IdType="pmc">5747522</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts JC, Condello C, Stohr J, Oehler A, Lee J, DeArmond SJ et al (2014) Serial propagation of distinct strains of Abeta prions from Alzheimer's disease patients. Proc Natl Acad Sci USA 111:10323&#x2013;10328. https://doi.org/10.1073/pnas.1408900111</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1408900111</ArticleId><ArticleId IdType="pubmed">24982139</ArticleId><ArticleId IdType="pmc">4104857</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts JC, Giles K, Grillo SK, Lemus A, DeArmond SJ, Prusiner SB (2011) Bioluminescence imaging of Abeta deposition in bigenic mouse models of Alzheimer's disease. Proc Natl Acad Sci USA 108:2528&#x2013;2533. https://doi.org/10.1073/pnas.1019034108</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1019034108</ArticleId><ArticleId IdType="pubmed">21262831</ArticleId><ArticleId IdType="pmc">3038719</ArticleId></ArticleIdList></Reference><Reference><Citation>Weissmann C, Li J, Mahal SP, Browning S (2011) Prions on the move. EMBO Rep 12:1109&#x2013;1117. https://doi.org/10.1038/embor.2011.192</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/embor.2011.192</ArticleId><ArticleId IdType="pubmed">21997298</ArticleId><ArticleId IdType="pmc">3207107</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickner RB, Edskes HK, Bateman DA, Gorkovskiy A, Dayani Y, Bezsonov EE et al (2015) Yeast prions: proteins templating conformation and an anti-prion system. PLoS Pathog 11:e1004584. https://doi.org/10.1371/journal.ppat.1004584</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004584</ArticleId><ArticleId IdType="pubmed">25654539</ArticleId><ArticleId IdType="pmc">4412292</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilham JM, Orru CD, Bessen RA, Atarashi R, Sano K, Race B et al (2010) Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog 6:e1001217. https://doi.org/10.1371/journal.ppat.1001217</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001217</ArticleId><ArticleId IdType="pubmed">21152012</ArticleId><ArticleId IdType="pmc">2996325</ArticleId></ArticleIdList></Reference><Reference><Citation>Wogulis M, Wright S, Cunningham D, Chilcote T, Powell K, Rydel RE (2005) Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death. J Neurosci 25:1071&#x2013;1080. https://doi.org/10.1523/JNEUROSCI.2381-04.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2381-04.2005</ArticleId><ArticleId IdType="pubmed">15689542</ArticleId><ArticleId IdType="pmc">6725948</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu JW, Breydo L, Isas JM, Lee J, Kuznetsov YG, Langen R et al (2010) Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation. J Biol Chem 285:6071&#x2013;6079. https://doi.org/10.1074/jbc.M109.069542</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.069542</ArticleId><ArticleId IdType="pubmed">20018889</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y, Ma B, McElheny D, Parthasarathy S, Long F, Hoshi M et al (2015) Abeta(1&#x2013;42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer's disease. Nat Struct Mol Biol 22:499&#x2013;505. https://doi.org/10.1038/nsmb.2991</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2991</ArticleId><ArticleId IdType="pubmed">25938662</ArticleId><ArticleId IdType="pmc">4476499</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, Hu X, Khant H, Ludtke SJ, Chiu W, Schmid MF et al (2009) Interprotofilament interactions between Alzheimer's Abeta1-42 peptides in amyloid fibrils revealed by cryoEM. Proc Natl Acad Sci USA 106:4653&#x2013;4658. https://doi.org/10.1073/pnas.0901085106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0901085106</ArticleId><ArticleId IdType="pubmed">19264960</ArticleId><ArticleId IdType="pmc">2660777</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Tarutani A, Newell KL, Murzin AG, Matsubara T, Falcon B et al (2020) Novel tau filament fold in corticobasal degeneration. Nature 580:283&#x2013;287. https://doi.org/10.1038/s41586-020-2043-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2043-0</ArticleId><ArticleId IdType="pubmed">32050258</ArticleId><ArticleId IdType="pmc">7148158</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Wu X, Li X, Jiang LL, Gui X, Liu Y et al (2018) TREM2 Is a receptor for beta-amyloid that mediates microglial function. Neuron 97(1023&#x2013;1031):e1027. https://doi.org/10.1016/j.neuron.2018.01.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.01.031</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler-Waldkirch S, Paolo DE, Sauer JF, Erny D, Savanthrapadian S, Loreth D et al (2018) Seed-induced Abeta deposition is modulated by microglia under environmental enrichment in a mouse model of Alzheimer's disease. EMBO J 37:167&#x2013;182. https://doi.org/10.15252/embj.201797021</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201797021</ArticleId><ArticleId IdType="pubmed">29229786</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou WQ, Puoti G, Xiao X, Yuan J, Qing L, Cali I et al (2010) Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol 68:162&#x2013;172. https://doi.org/10.1002/ana.22094</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22094</ArticleId><ArticleId IdType="pubmed">20695009</ArticleId><ArticleId IdType="pmc">3032610</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>